Consistent with our finding that MEK/ERK signaling also enhances activation of CREB, a recent study has demonstrated by analysis of biopsies from BRAFV600E melanoma patients that activation of CREB was supressed by inhibition of mutant BRAF or MEK but restored in relapsing melanomas [57]. Here, CREB1 is linked to melanoma.